A 62-year-old woman is evaluated in the hospital for new-onset right leg swelling and pain… — USMLE Step 3

A $62$ -year-old woman is evaluated in the hospital for new-onset right leg swelling and pain. She was admitted $6$ days ago for an acute pulmonary embolism and was subsequently started on a continuous unfractionated heparin infusion. On admission, her platelet count was $260,000/\text{mm}^3$ . Today, her vital signs are temperature $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure $130/80\text{ mmHg}$ , pulse $92/\text{min}$ , and respirations $16/\text{min}$ . Physical examination reveals a visibly swollen right calf that is tender to palpation. A venous Doppler ultrasound of the right lower extremity demonstrates an acute deep venous thrombosis in the right femoral vein. Laboratory studies from this morning show a platelet count of $110,000/\text{mm}^3$ and an activated partial thromboplastin time (aPTT) of $65\text{ seconds}$ (therapeutic range: $60-80\text{ seconds}$ ). Which of the following is the most appropriate next step in the management of this patient?

A
Discontinue unfractionated heparin and transition to subcutaneous enoxaparin
B
Continue the current heparin infusion and order a serotonin release assay
Discontinue unfractionated heparin and start an argatroban infusionAnswer
D
Continue the current heparin infusion and administer a pool of donor platelets
E
Decrease the unfractionated heparin infusion rate to target a lower aPTT

Answer

Discontinue unfractionated heparin and start an argatroban infusion

The correct action is to immediately discontinue all heparin products and begin alternative anticoagulation with a direct thrombin inhibitor, such as argatroban. This patient presents with a classic picture of Type II Heparin-Induced Thrombocytopenia (HIT). The diagnosis is heavily supported by her clinical presentation: a platelet count drop of greater than

50\%

from baseline, an onset precisely

5

10

days after heparin initiation, and the development of a new thrombotic complication (deep venous thrombosis) while on therapy. These factors yield a high probability '4Ts' score. Because HIT is an intensely prothrombotic state driven by IgG antibodies against the heparin-PF4 complex, all heparin exposure must be eliminated instantly. To protect against life-threatening thromboses, an alternative non-heparin anticoagulant must be instituted immediately.

Step-by-Step Solution

Evaluate the clinical criteria for Heparin-Induced Thrombocytopenia (HIT) using the 4Ts score.

The patient has a platelet drop of >50% (Thrombocytopenia = 2 points), onset 6 days after heparin initiation (Timing = 2 points), and a new deep venous thrombosis (Thrombosis = 2 points), indicating a high probability of HIT.

Accurate calculation of the 4Ts score determines whether immediate intervention for HIT is necessary before confirmatory labs result.

Determine the immediate intervention required for suspected HIT.

All forms of heparin must be discontinued instantly.

Continuing heparin or switching to closely related drugs will worsen the immune-mediated platelet activation and thrombosis.

Select the appropriate alternative anticoagulation therapy.

A non-heparin anticoagulant, such as a direct thrombin inhibitor (argatroban, bivalirudin) or fondaparinux, must be initiated.

The patient remains in a highly hypercoagulable state and requires immediate, safe anticoagulation to treat both the original pulmonary embolism and the new deep venous thrombosis.

Key Concept

Diagnosis and management of Heparin-Induced Thrombocytopenia (HIT)

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic